Stay updated on IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page.

Latest updates to the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page
- Check5 days agoChange DetectedThe update appears to be a cosmetic refresh of the history page with no substantive changes to trial data (status, design, or contacts). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check33 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference11%

- Check40 days agoChange DetectedThe page version is updated from v3.0.2 to v3.1.0, indicating a new release.SummaryDifference0.3%

- Check55 days agoChange DetectedUpdated revision to v3.0.2; removed the Back to Top link; no other significant content changes.SummaryDifference0.6%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.6%

- Check69 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, while also removing specific location details such as state, country, and city information.SummaryDifference32%

Stay in the know with updates to IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page.